CN1203075C - Prepn of cefotaxime - Google Patents

Prepn of cefotaxime Download PDF

Info

Publication number
CN1203075C
CN1203075C CN 02118226 CN02118226A CN1203075C CN 1203075 C CN1203075 C CN 1203075C CN 02118226 CN02118226 CN 02118226 CN 02118226 A CN02118226 A CN 02118226A CN 1203075 C CN1203075 C CN 1203075C
Authority
CN
China
Prior art keywords
acetate
sodium
amino
organic solvent
thiomethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN 02118226
Other languages
Chinese (zh)
Other versions
CN1453280A (en
Inventor
崔建彤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhejiang Hisun Pharmaceutical Co Ltd
Original Assignee
Zhejiang Hisun Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang Hisun Pharmaceutical Co Ltd filed Critical Zhejiang Hisun Pharmaceutical Co Ltd
Priority to CN 02118226 priority Critical patent/CN1203075C/en
Publication of CN1453280A publication Critical patent/CN1453280A/en
Application granted granted Critical
Publication of CN1203075C publication Critical patent/CN1203075C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Cephalosporin Compounds (AREA)

Abstract

The present invention relates to an improved method for preparing ceftiofur sodium, which comprises: 7-amino-3-[(2-furancarbonyl)thiomethyl]cephalosporanic acid reacts with 2-(2-amino-4-thiazolyl)-2-cis-methoxyimine acetate-2-mercaptobenzothiazole thioester in an aqueous solution of proper organic solvents under the existence of any one kind of triethylamine, trimethylamine, N-ethyl piperidine, dimethylamino pyridine, 1, 4-dimethylpiperazine and pyridine, the aqueous solution obtained by reactions is treated by any one kind of salts of diphenylamine, N-tert-butyl-cyclohexylamine, diisopropylamine, procaine, dicyclohexylamine and N, N-diphenyl ethylenediamine to obtain precipitates, and the precipitates react with sodium acetate and 2-ethyl sodium caproate in proper solvents to obtain the ceftiofur sodium.

Description

A kind of Preparation of ceftiofur sodium method
The present invention be a kind of preparation (6R, 7R)-7-[2-(thiazolamine-4-yl)-(Z)-2-(methoxy imino) acetamido]-3-[(2-furans carbonyl) thiomethyl]-3-cephem-4-carboxylic acid sodium is the new method of ceftiofur sodium (I).
Figure C0211822600031
Patent WO87/01117 has set forth the method for preparing ceftiofur sodium (I) from ceftiofur hydrochloride (IV),
Figure C0211822600032
In addition, patent EP0180372 has set forth the method for preparing ceftiofur hydrochloride (IV) from the ceftiofur (III) of ceftiofur (II) or trityl as protecting group.That is to say that prior art is told us, ceftiofur sodium can prepare by ceftiofur hydrochloride from ceftiofur or trityl ceftiofur.We are surprised to find a kind of new preparation ceftiofur sodium now, and it is simple to have method, and yield is higher, the advantage that product purity is high.Therefore, purpose of the present invention just provides a kind of method that more effectively prepares ceftiofur sodium.
The present invention prepares ceftiofur sodium by following synthetic route
Reaction (1) is finished at-20 ℃ to 30 ℃, and preferable reaction temperature is-5 ℃ to 25 ℃, preferred especially 0 ℃ to 10 ℃.
Reaction (1) is carried out in a kind of appropriate organic solvent aqueous solution, organic solvent is tetrahydrofuran (THF), N,N-DIMETHYLACETAMIDE, dimethyl formamide, dioxane, glycol dimethyl ether or above-mentioned suitable mixed solvent, and preferred solvent is tetrahydrofuran (THF), N,N-DIMETHYLACETAMIDE or both mixed solvents.
Reaction (1) should be carried out in the presence of a kind of organic amine, and organic amine is Dimethylamino pyridine, Trimethylamine 99, pyridine, 1, the 4-lupetazin, and N-ethylpiperidine, triethylamine, preferred organic amine is a triethylamine.
The salt (V) that reaction generates is not separated from reaction solution, and directly uses N, and N-dibenzyl-ethylenediamin acetate is handled, and obtains purer salt (VI) quantitatively thereby can be actually.
N, the N-dibenzyl-ethylenediamin can be used dicyclohexyl amine, pentanoic, Diisopropylamine, N-tertiary butyl hexahydroaniline and procaine base substitute.
Salt (VI) appropriate organic solvent such as tetrahydrofuran (THF), ketone such as acetone, methyl ethyl ketone, methyl iso-butyl ketone (MIBK), alcohol as methyl alcohol and ethanol in or in the above-mentioned aqueous solutions of organic solvent with sodium-acetate, 2 ethyl hexanoic acid sodium prepared in reaction ceftiofur sodium (I).
Whole inventive method prepares ceftiofur sodium (I) total efficiency and is stabilized in and is higher than 80.0%.
Therefore, the present invention relates to the i.e. (6R of a kind of preparation ceftiofur sodium, 7R)-7-[2-(thiazolamine-4-yl)-(Z)-2-(methoxy imino) acetamido]-3-[(2-furans carbonyl) thiomethyl]-method of 3-cephem-4-carboxylic acid sodium, it comprises 7-amino-3-[(2-furans carbonyl) thiomethyl] Cephalosporanic acid and 2-(2-amino-4 thiazolyl)-2-methoxy imino acetate-2-mercaptobenzothiazole thioesters be at organic solvent and triethylamine, dimethylamino pyridine, Trimethylamine 99, pyridine, 1, in the aqueous solution under any amine exists in 4-lupetazin and the N-ethylpiperidine,-20 ℃ to 30 ℃ reactions, and then use dicyclohexyl amine, pentanoic, Diisopropylamine, N-tertiary butyl hexahydroaniline, procaine base and N, the salt of any alkali is handled and is obtained precipitation in the N-dibenzyl-ethylenediamin, and this is deposited in organic solvent or reacts with sodium-acetate or 2 ethyl hexanoic acid sodium in aqueous solutions of organic solvent.
Be embodiments of the invention below, described embodiment just is used for illustrating the present invention, rather than limits the present invention.
Embodiment 1
(6R, 7R)-7-[2-(thiazolamine-4-yl)-(Z)-2-(methoxy imino) acetamido]-3-[(2-furans carbonyl) thiomethyl]-3-cephem-4-carboxylic acid N, the preparation of N-dibenzyl-ethylenediamin acetate
With the 30ml N,N-DIMETHYLACETAMIDE, the mixing solutions of 200ml tetrahydrofuran (THF) and 200ml water is cooled to 0-3 ℃, add 20g 7-amino-3-[(2-furans carbonyl) thiomethyl] Cephalosporanic acid and 23.16gAE active thioester, under the 0-3 ℃ of stirring 13.62ml triethylamine is added dropwise in the above-mentioned suspension, extremely transparent 0-3 ℃ of reaction.The 200ml ethyl acetate is added above-mentioned transparent liquid, stir evenly, leave standstill, tell water, stir adding 10.44gN down, N-dibenzyl-ethylenediamin acetate, add the 150ml methylene dichloride then, obtain precipitation, filter, drying obtains 43.0g 7-[2-(thiazolamine-4-yl)-(Z)-2-(methoxy imino) acetamido under the vacuum]-3-[(2-furans carbonyl) thiomethyl]-3-cephem-4-carboxylic acid N, N-dibenzyl-ethylenediamin acetate (yield 93.68%).
Embodiment 2
With 10g 7-[2-(thiazolamine-4-yl)-2-(methoxy imino) acetamido]-3-[(2-furans carbonyl) thiomethyl]-3-cephem-4-carboxylic acid N, N-dibenzyl-ethylenediamin acetate adds in the 60ml tetrahydrofuran (THF) and the 4.4ml aqueous solution, add 4.56g 2 ethyl hexanoic acid sodium then, stirred 15 minutes, add the 350ml tetrahydrofuran (THF), filter solids, use the 30ml washing with acetone again three times, the dry 5.67g ceftiofur sodium (HPLC purity is not less than 98.0%, yield 85.4%) that gets under vacuum.
Embodiment 3
With 20g ceftiofur N, N-dibenzyl-ethylenediamin acetate adds in the 100ml tetrahydrofuran (THF) and the 8.8ml aqueous solution, add in the 37ml tetrahydrofuran solution of 9.12g 2 ethyl hexanoic acid sodium, stirred 15 minutes, add the 680ml tetrahydrofuran (THF), filter solids, use the 60ml washing with acetone again three times, vacuum-drying gets 11.42g ceftiofur sodium (HPLC purity is not less than 98.0%, yield 86.0%).
Embodiment 4
With 10g ceftiofur N, N-dibenzyl-ethylenediamin acetate adds in the 100ml acetone and the 25ml aqueous solution, adds the 1.59g sodium-acetate, stirred 30 minutes, and added 230ml acetone, filter solids, with 30ml washing with acetone three times, vacuum-drying obtains the 5.84g ceftiofur sodium.HPLC purity is not less than 98.0%, yield 88.0%.
Embodiment 5
With 20g ceftiofur N, N-dibenzyl-ethylenediamin acetate adds in the 184ml acetone and the 46ml aqueous solution, add the 3.17g sodium-acetate and be dissolved in 4ml water and 16ml acetone mixed solution, stirred 30 minutes, add 460ml acetone, filter solids, with 60ml washing with acetone three times, obtain the 11.8g ceftiofur sodium.HPLC purity is not less than 98.0%, yield 88.9%.

Claims (7)

1. one kind prepares the i.e. (6R of ceftiofur sodium, 7R)-7-[2-(thiazolamine-4-yl)-(Z)-2-(methoxy imino) acetamido]-3-[(2-furans carbonyl) thiomethyl]-method of 3-cephem-4-carboxylic acid sodium, it comprises 7-amino-3-[(2-furans carbonyl) thiomethyl] Cephalosporanic acid and 2-(2-amino-4 thiazolyl)-2-methoxy imino acetate-2-mercaptobenzothiazole thioesters be at organic solvent and triethylamine, dimethylamino pyridine, Trimethylamine 99, pyridine, 1, in the aqueous solution under any amine exists in 4-lupetazin and the N-ethylpiperidine,-20 ℃ to 30 ℃ reactions, and then use dicyclohexyl amine, pentanoic, Diisopropylamine, N-tertiary butyl hexahydroaniline, procaine base and N, the salt of any alkali is handled and is obtained precipitation in the N-dibenzyl-ethylenediamin, and this is deposited in organic solvent or reacts with sodium-acetate or 2 ethyl hexanoic acid sodium in aqueous solutions of organic solvent.
2. the method for preparing ceftiofur sodium according to claim 1 is characterized in that 7-amino-3-[(2-furans carbonyl) thiomethyl] Cephalosporanic acid and 2-(2-amino-4-thiazolyl)-2-methoxy imino acetate 2-mercaptobenzothiazole dredge that said organic solvent is tetrahydrofuran (THF), N,N-DIMETHYLACETAMIDE, dimethyl formamide, dioxane, glycol dimethyl ether or above-mentioned suitable mixed solvent in the ester reaction.
3. the method for preparing ceftiofur sodium according to claim 2 is characterized in that said organic solvent is tetrahydrofuran (THF), N,N-DIMETHYLACETAMIDE or both mixed solvents.
4. the method for preparing ceftiofur sodium according to claim 1 is characterized in that 7-amino-3-[(2-furans carbonyl) thiomethyl] Cephalosporanic acid and 2-(2-amino-4-thiazolyl)-2-methoxy imino acetate 2-mercaptobenzothiazole thioesters be reflected in organic solvent and the triethylamine aqueous solution under existing and carry out.
5. the method for preparing ceftiofur sodium according to claim 1, it is characterized in that 7-amino-3-[(2-furans carbonyl) thiomethyl] Cephalosporanic acid and 2-(2-amino-4-thiazolyl)-2-methoxy imino acetate 2-mercaptobenzothiazole thioesters reaction back N, N-dibenzyl-ethylenediamin acetate is handled and is obtained precipitation.
6. the method for preparing ceftiofur sodium according to claim 1, it is characterized in that ceftiofur sodium is by 7-[2-(thiazolamine-4-base-2-(methoxy imino) acetamido)-3-[(2-furans carbonyl) thiomethyl]-3-cephem-4-carboxylic acid N, N-dibenzyl-ethylenediamin acetate is in aqueous solutions of organic solvent and sodium-acetate or 2 ethyl hexanoic acid sodium reaction and making.
7. the method for preparing ceftiofur sodium according to claim 1, it is characterized in that 7-amino-3-[(2-furans carbonyl) thiomethyl] Cephalosporanic acid and 2-(2-amino-4-thiazolyl)-2-methoxy imino acetate-2-mercaptobenzothiazole thioesters be in the aqueous solution of the mixed solvent of tetrahydrofuran (THF) and N,N-DIMETHYLACETAMIDE and triethylamine,-20 ℃ to 30 ℃ reactions, and then use N, N-dibenzyl-ethylenediamin acetate is handled and is obtained precipitation, and this is deposited in organic solvent or reacts with sodium-acetate or 2 ethyl hexanoic acid sodium in aqueous solutions of organic solvent.
CN 02118226 2002-04-26 2002-04-26 Prepn of cefotaxime Expired - Fee Related CN1203075C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 02118226 CN1203075C (en) 2002-04-26 2002-04-26 Prepn of cefotaxime

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 02118226 CN1203075C (en) 2002-04-26 2002-04-26 Prepn of cefotaxime

Publications (2)

Publication Number Publication Date
CN1453280A CN1453280A (en) 2003-11-05
CN1203075C true CN1203075C (en) 2005-05-25

Family

ID=29257317

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 02118226 Expired - Fee Related CN1203075C (en) 2002-04-26 2002-04-26 Prepn of cefotaxime

Country Status (1)

Country Link
CN (1) CN1203075C (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101245078B (en) * 2007-03-19 2010-05-26 齐鲁动物保健品有限公司 Benzathine salt of ceftiofur, preparation method and application thereof
CN101654458B (en) * 2009-09-28 2012-01-04 洛阳普莱柯生物工程有限公司 Preparation method of hydrochloric acid ceftiofur
CN102093391A (en) * 2009-12-09 2011-06-15 上海华理生物医药有限公司 New preparation method of ceftiofur sodium
CN101829063B (en) * 2010-03-18 2012-01-25 青岛康地恩药业有限公司 Lung targeting microsphere of veterinary ceftiofur hydrochloride and preparation method
CN102584855B (en) * 2012-02-16 2014-06-25 青岛科技大学 Improved method for preparing ceftiofur
CN111171051B (en) * 2020-03-05 2021-09-10 山西阳和医药技术有限公司 Preparation method of cefixime
CN115772179A (en) * 2022-12-09 2023-03-10 山东鑫泉医药有限公司 Recrystallization method of ceftiofur sodium

Also Published As

Publication number Publication date
CN1453280A (en) 2003-11-05

Similar Documents

Publication Publication Date Title
CN1235902C (en) Crystalline acid salts of cefdinir and process for preparing cefdinir using same
CN1203075C (en) Prepn of cefotaxime
CN101631872B (en) Process for the preparation of beta-lactam compounds
CN102002060B (en) Preparation method of cefozopran hydrochloride
CN101337971B (en) Method for synthesizing antibiotic cefepime hydrochloride
CN101058584A (en) Method of preparing cefprozil parent nucleus 7-amino-3-propenylcephalosporanic acid
CN1044246C (en) Bicyclic beta-lactam/paraben complexes
JP4856795B2 (en) Novel salts in the production of cephalosporin antibiotics.
CN1232512C (en) Process for preparing anhydride of aminothiazole derivative
JP3751880B2 (en) Method for producing high-purity cefpodoxime proxetil
CN1520418A (en) Process for prepn. of cefpodoxime acid
CN1058593A (en) Preparation method and intermediate with beta-lactam of aminothiazole (imino-ethoxyacetic acid) acetic acid side chain
CN1176089C (en) Preparation of cephalosporin compound
CN1148371C (en) Process for preparing 7-amino-3-methoxymethyl-3-cephem-4-carboxylic acid
CN107286183B (en) Refining method of cefixime
KR20010043038A (en) A METHOD FOR CRYSTALLIZING A β-LACTAM ANTIBIOTIC
CN101130803A (en) Method for enzymatically synthesizing beta-lactam antibiotic in organic solvent
US5302713A (en) Method for the preparation of Δ3 -7-substituted amino desacetoxy cephalosporanic acid
CN1155603C (en) Process for producing 3-cephem compounds
CN1167112A (en) Process for producing cephalosporin antibiotics
CN1958591A (en) Method for preparing intermediate in cephalosporins, and method for preparing ceftizoxime alapivoxil
CN1159320C (en) Cephalo olefine onium salt compound and its preparing method, and method for synthesizing cephalo pyoxime with said compound
JPS61122290A (en) Manufacture of cephalosporin derivative
CN1962666A (en) Cepham antibiotics and its intermediate preparation method
CN103635585A (en) Process for preparing 3'-thiosubstituted cephalosporins employing a penicillin G acylase

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20050525

Termination date: 20190426

CF01 Termination of patent right due to non-payment of annual fee